{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-040724","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.556404+00:00","generated_at":"2026-05-22T07:47:28.885699+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Adial raises $2.75M via warrant inducement; existing warrants exercised at $0.74","bullets":["Existing Series B and C warrants for 3,718,440 shares exercised at reduced price of $0.74 per share.","Company issued new unregistered Series B-1 (2.48M shares) and C-1 (4.03M shares) warrants at $0.74 exercise price.","New warrants exercisable only after stockholder approval; Series B-1 expire in 5 years, C-1 in 18 months.","Net proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-040724","json":"https://secwatch.observer/filing/0001213900-25-040724.json","markdown":"https://secwatch.observer/filing/0001213900-25-040724.md","text":"https://secwatch.observer/filing/0001213900-25-040724.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025040724/0001213900-25-040724-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025040724/ea0241155-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T07:47:28.885699+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}